SIBN
SI-BONE, Inc.
NASDAQ · USHealthcareMedical - Devices
$17.12-1.50%
Price as of Jul 20, 2026
SIBN financials
SI-BONE, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $200.9M | $167.2M | $138.9M | $106.4M |
| Cost of revenue | $41.0M | $35.1M | $29.5M | $15.7M |
| Gross profit | $159.9M | $132.1M | $109.4M | $90.7M |
| Operating expenses | $182.2M | $167.4M | $156.4M | $150.3M |
| Operating income | -$22.3M | -$35.2M | -$46.9M | -$59.6M |
| Net income | -$18.9M | -$30.9M | -$43.3M | -$61.3M |
| EBITDA | -$10.9M | -$23.1M | -$34.4M | -$55.0M |
| Basic EPS | $-0.44 | $-0.75 | $-1.13 | $-1.79 |
| Diluted EPS | $-0.44 | $-0.75 | $-1.13 | $-1.79 |
| Balance sheet | ||||
| Cash & equivalents | $42.2M | $34.9M | $33.3M | $20.7M |
| Total assets | $238.6M | $230.4M | $230.4M | $157.6M |
| Total liabilities | $61.0M | $63.5M | $61.0M | $59.3M |
| Stockholders’ equity | $177.5M | $167.0M | $169.4M | $98.3M |
| Total debt | $1.1M | $37.5M | $39.0M | $39.4M |
| Net debt | -$41.1M | $2.5M | $5.7M | $18.7M |
| Cash flow | ||||
| Operating cash flow | -$675.0K | -$12.4M | -$18.7M | -$41.7M |
| Capital expenditure | -$8.4M | -$10.5M | -$7.8M | -$9.5M |
| Free cash flow | -$9.1M | -$22.9M | -$26.5M | -$51.2M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |